9CUM

Q67H mutant of R67 DHFR complexed with Congo Red

Summary for 9CUM

• Entry DOI: 10.2210/pdb9cum/pdb
• Descriptor: Dihydrofolate reductase type 2, sodium 3,3'-(1E,1'E)-biphenyl-4,4'-diylbis(diazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate), SODIUM ION, ... (6 entities in total)
• Functional Keywords: oxidoreductase, congo red, inhibitor, complex
• Biological source: Escherichia coli
• Total number of polymer chains: 1
• Total formula weight: 7816.72

Authors

Narayana, N.,Narendra, A.N. (deposition date: 2024-07-26, release date: 2025-02-19, Last modification date: 2025-02-26)

Primary citation

Narendra, A.N.,Howell, E.E.,Narayana, N.
Crystal structure of the plasmid-encoded R67 dihydrofolate reductase complexed with Congo red an amyloid binding dye.
Sci Rep, 15:5212-5212, 2025

PubMed Abstract: Plasmid-encoded bacterial R67 dihydrofolate reductase (DHFR) catalyzes the same reaction as the chromosomal counterpart but is highly resistant to the widely used antibiotic Trimethoprim (TMP) unlike the chromosomal enzyme. The structure of Q67H mutant of R67 DHFR complexed with a non-specific inhibitor Congo red (CGR) has been determined at 1.15 Å resolution. In the F-F map, one of the two naphthalene moieties in CGR is clearly observed, however, the biphenyl linker and the other naphthalene moiety are not seen owing to flexibility. CGR does not utilize its twofold axis to align with any of the three crystallographic twofold axes of the tetrameric protein instead, it binds like the asymmetrical folate and NADP at any one of the four symmetry-related positions in the active site pore. The naphthalene moiety with exocyclic sulphonate ion and amino group, interacts with residues 66-68 from all four protomers via metal-based ionic, van der Waals, stacking, and hydrogen bonding interactions. Preliminary modeling studies suggest variant fragments of CGR targeting one or both Lys32 residues at the site of enlarging pore may yield specific and potent inhibitors. Based on the CGR - protein interactions in the present work, we propose a putative model for the binding of CGR to cross-β amyloid.

PubMed: 39939735
DOI: 10.1038/s41598-025-89539-3

Experimental method

X-RAY DIFFRACTION (1.15 Å)